If you liked this article you might like

Bristol-Myers Squibb Reiterated 'Buy' at Jefferies, Analysts Respond
Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open
Is It Time to Buy Beaten-Down Bristol-Myers Squibb Stock?
Allergan, Apple, Facebook: Doug Kass' Views